Document is current
Any future updates will be listed below
-
Authors
Halder, Nabanita
Perkerson, Ralph
Kanekiyo, Takahisa
Rutt, Amy L. https://orcid.org/0000-0002-7704-6328
- License Information
-
More Information
Article History
Accepted: 25 February 2025
First Online: 28 February 2025
Change Date: 3 July 2025
Change Type: Update
Change Details: The original online version of this article was revised: 1. Added the statement, “Recombinant human HGF was provided by Kringle Pharma, Inc. (Osaka, Japan).” 2. Acknowledge Kringle Pharma, Inc for providing Recombinant human HGF in the Acknowledgements.
Declarations
:
: The stem cells used were research grade. Therefore, they would have been derived from commercial deidentified bone marrow. No IRB was required.
: The manuscript does not contain any individual person’s data in any form.
: There are no competing or conflicts of interest
